Pharmacist Explains TrumpRx and How it Works

Quick Overview

The TrumpRx discount program, which claims to offer the world's lowest prescription drug prices, is largely a rebrand of GoodRx with no independent price improvement for 34 of 43 drugs reviewed, primarily functioning by redirecting users to existing manufacturer discount programs or using standard pharmacy coupon codes that rely on insurance billing loopholes.

Key Points: The author cross-referenced all 43 drugs listed on TrumpRx with GoodRx pricing data and found that 34 of the drugs are essentially a straight rebrand of GoodRx with no independent price improvement. For the 34 rebranded drugs, TrumpRx coupons use the exact same BIN and PCN codes as GoodRx, indicating they operate through the same existing infrastructure. For 8 drugs, TrumpRx redirects users to manufacturer direct purchase programs (like AstraZeneca Direct or Eli Lilly's program) that existed prior to TrumpRx's launch. The primary mechanism exploited is the difference between the price insurance is billed for and the negotiated price, allowing coupons (like those from TrumpRx or GoodRx) to offer significant, though often not the 'world's lowest,' savings. The speaker highlights that for a drug like Pristiq, the TrumpRx price was $200.10 compared to an international price of $95.00 in Australia, contradicting the 'lowest prices globally' claim. The system works because pharmacies are incentivized to overbill insurance companies (sometimes by 5x the actual cost) so they can apply the coupon discount and still profit from the insurance reimbursement. The speaker recommends alternatives like RxOutreach.gov and manufacturer free trial offers (like Eliquis's 30-day trial) as potentially better options than TrumpRx for certain medications.

Context: The video features pharmacist Grant Harting, identifying himself as a licensed pharmacist and medication pricing expert, who investigates the claims made by the TrumpRx prescription discount program. TrumpRx markets itself as a "Most-Favored-Nation" pricing program that negotiates directly with manufacturers to offer Americans the lowest available prices globally, which the speaker finds to be a dubious claim.